Femera 2.5 mg (30 Tablets) | Letrozole Breast Cancer Treatment | Novartis | Femera

Femera 2.5 mg is a critical prescription medication containing the active ingredient Letrozole. It is a leading oral treatment for hormone receptor-positive (HR+) breast cancer, primarily prescribed for women who have completed menopause. This 30-tablet package from Novartis is a non-steroidal aromatase inhibitor designed to reduce estrogen levels in the body.

SKU: FEME-2.5MG

Details

Manufacturer

Novartis

Active Ingredient

Letrozole

Dosage

2.5 mg

Form

Tablet

10 People watching this product now!

Description

Femera 2.5 mg Letrozole (30 Tablets)

Femera 2.5 mg is a critical prescription medication containing the active ingredient Letrozole. It is a leading oral treatment for hormone receptor-positive (HR+) breast cancer, primarily prescribed for women who have completed menopause. This 30-tablet package from Novartis is a non-steroidal aromatase inhibitor designed to reduce estrogen levels in the body.

 

Product Overview: Femera 2.5 mg (Letrozole)

Femera 2.5 mg (Letrozole) is a vital therapy in oncology, widely used as a first-line treatment for hormone receptor-positive breast cancer in postmenopausal women.

Manufactured by Novartis, Femera is a potent aromatase inhibitor. Its primary mechanism is to significantly lower circulating estrogen levels. This is crucial because many forms of breast cancer (HR+) use estrogen as “fuel” to grow and spread. By reducing the body’s estrogen supply, Femera helps to slow or stop the growth of these cancer cells.

It is commonly prescribed as an adjuvant therapy (after surgery) to help prevent cancer recurrence, or as a treatment for advanced (metastatic) breast cancer.

 

How Does Femera 2.5 mg (Letrozole) Work?

The active ingredient, Letrozole, blocks a key enzyme in the body called aromatase. In postmenopausal women, the aromatase enzyme is responsible for converting androgens (other hormones) into estrogen, primarily in fatty tissues.

By inhibiting this enzyme, Femera 2.5 mg effectively stops this conversion, leading to a significant reduction in the total amount of estrogen in the body. This “starves” the hormone-sensitive cancer cells, hindering their ability to grow and multiply.

 

Key Product Details

Feature Detail
Brand: Femera
Manufacturer: Novartis
Active Ingredient: Letrozole
Dosage Strength: 2.5 mg
Form: Film-coated tablet
Package Size: 30 tablets (Approx. 1-month supply)
Indication: Hormone receptor-positive breast cancer (postmenopausal)

 

Dosage and Administration

 

The standard recommended dosage is one 2.5 mg tablet taken once daily.

Important: This is a prescription-only medication and must be taken under the strict supervision of a healthcare professional, typically an oncologist. Swallow the tablet whole with water; it can be taken with or without food. It is recommended to take it at the same time each day. Do not stop taking Femera unless instructed by your doctor.


 

Frequently Asked Questions (FAQ) about Femera 2.5 mg

 

How long do I need to take Femera 2.5 mg?

The duration of treatment depends on your specific medical condition. For adjuvant therapy (after surgery), it is often prescribed for 5 years, sometimes extended up to 10 years, to minimize the risk of cancer returning. Your doctor will determine the appropriate duration for you.

 

What is the difference between Letrozole (Femera) and Tamoxifen?

Both are hormone therapies for breast cancer, but they work differently. Tamoxifen (a SERM) works by blocking estrogen from attaching to the cancer cells. Femera (an aromatase inhibitor) works by stopping the body from producing estrogen in the first place (in postmenopausal women). Your doctor will choose the best treatment for your specific type of cancer and menopausal status.

 

Is Femera used for hormone regulation outside of cancer?

Femera’s primary, approved use is for breast cancer. However, because it powerfully modulates hormone levels by lowering estrogen, it is sometimes used “off-label” by specialists to treat other conditions, such as inducing ovulation in women with PCOS (polycystic ovary syndrome) for fertility purposes. This use must be strictly monitored by a physician.

 

What are the common side effects of Femera 2.5 mg?

Since Femera significantly lowers estrogen, many side effects are similar to menopausal symptoms. Common side effects may include hot flashes, joint pain (arthralgia), fatigue, headache, sweating, and nausea. It can also lead to bone thinning (osteoporosis), so your doctor will likely monitor your bone density.


 

Important Safety Information

Femera (Letrozole) is intended for use only in women who are postmenopausal. It must not be taken by women who are or may become pregnant, as it can cause serious fetal harm.

Before taking Femera 2.5 mg, you must inform your doctor of your complete medical history, including:

  • If you are still in perimenopause (not fully postmenopausal)
  • High cholesterol levels
  • A history of osteoporosis, osteopenia, or bone fractures
  • Severe liver or kidney disease

Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Femera (Letrozole) is a potent prescription medication. Always consult with your oncologist or a qualified healthcare provider for any health-related questions.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Femera 2.5 mg (30 Tablets) | Letrozole Breast Cancer Treatment | Novartis | Femera”

Your email address will not be published. Required fields are marked *

1 2 3 4 5
1 2 3 4 5
1 2 3 4 5